Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma

Figure 6

Identification of two subgroups with DLBCL patients by MTGs. (a) Consensus matrix legend. (b) Consensus clustering matrix with DLBCL samples for k = 2. (c) Consensus cluster cumulative distribution function (CDF) for k = 2–9. (d) Relative change in area under the CDF curve for k = 2–9. (e) Principal component analysis (PCA) of the total mRNA expression profile of MTGs in the GEO training dataset. DLBCL patients in the cluster 1 are marked with red, the cluster 2 are marked with blue. (f) Kaplan–Meier OS curves for two subgroups.

(a)

(b)

(c)

(d)

(e)

(f)